Ticker

CALGARY, Alberta, April 16, 2026 (GLOBE NEWSWIRE) -- Marvel Biosciences Corp. (TSXV: MRVL | OTC: MBCOF), and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively “Marvel” or the “Company”), a biotechnology company developing novel therapies for neurological and neurodevelopmental disorders, today announces it has identified two lead pediatric-friendly liquid formulations of its patented lead…

Strong recurring revenues, rising AI adoption and alignment with value-based care trends position NRC to capitalize on growing demand for patient-centric healthcare solutions.

LINCOLN, Neb. & ATLANTA--(BUSINESS WIRE)-- #HealthcareExperienceManagement--Piedmont, a Georgia-based healthcare system with nationally-ranked clinical programs, has named NRC Health, the leader in healthcare experience management, as its new strategic experience partner to support the organization's mission-driven growth and commitment to making a positive difference in every life it touches. The enterprise-wide…

Shares of National Research Corporation (NASDAQ: NRC - Get Free Report) crossed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $15.84 and traded as high as $18.31. National Research shares last traded at $17.73, with a volume of 135,330 shares. Wall Street

MONTREAL, March 17, 2026 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV: FLT) (OTCQB: TAKOF) (FSE: ABB.F) (“Volatus” or the “Company”), a Canadian aerospace and defence company delivering integrated uncrewed systems and mission-critical operational services, today announced it has been approved for non-dilutive funding support of up to $320,000 from the National Research Council of Canada Industrial Research…